Related Experiment Videos
Cytogenetic markers of host susceptibility in carcinogenesis
IARC Scientific Publications
|January 1, 1983
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Cytogenetic, clinical, and morphologic correlations in 78 cases of fibromatosis: a report from the CHAMP Study Group. CHromosomes And Morphology.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2000
Karyotypic characterization of urinary bladder transitional cell carcinomas.
Genes, chromosomes & cancer·2000
Cytogenetic and FISH studies of a single center consecutive series of 152 childhood acute lymphoblastic leukemias.
European journal of haematology·2000
RT-PCR analysis of the MOZ-CBP and CBP-MOZ chimeric transcripts in acute myeloid leukemias with t(8;16)(p11;p13).
Genes, chromosomes & cancer·2000
Practical approaches to control mycotoxins.
IARC scientific publications·2013
Economics of mycotoxins: evaluating costs to society and cost-effectiveness of interventions.
IARC scientific publications·2013
Risk assessment and risk management of mycotoxins.
IARC scientific publications·2013
Mycotoxins and human health.
IARC scientific publications·2013
Effects in food-producing animals.
IARC scientific publications·2013
Analysis of mycotoxins.
IARC scientific publications·2013
An integrative clinical-molecular model as an auxiliary predictive tool for glioma malignancy grade.
Neurological research·2026
Evaluating adenoma detection and miss rates in tandem colonoscopy: Limitations of surrogate quality indicators.
Advances in clinical and experimental medicine : official organ Wroclaw Medical University·2026
Predicting Radioiodine Therapy Response in Advanced and Recurrent Thyroid Cancer.
Endocrine-related cancer·2026
Refining risk stratification after indeterminate urinary cytology: Evidence from Bladder EpiCheck.
Cancer cytopathology·2026
PGR expression as a pharmacogenomic companion biomarker to GENE70-derived genomic risk in ER-positive/HER2-negative breast cancer.
Pakistan journal of pharmaceutical sciences·2026